The FDA has issued a warning to restaurants, retailers, and consumers in Arizona and other states about certain frozen, raw, ...

The Food and Drug Administration has issued a warning to restaurants, retailers and consumers in Arizona and other states ...

Norovirus is a leading cause of acute gastroenteritis ... followed by an End of Phase 2 meeting with the U.S. Food and Drug Administration (FDA). A Phase 3 trial could then begin as early as ...

In vitro testing with CDI-988 demonstrated superior broad-spectrum antiviral activity against major norovirus variants BOTHELL, W ...

Actively screening for the 10,000 participant portion of COVID-19 Phase 2b trial; Dosing expected to begin in second quarter of 2025 Completed enrollment of Phase 1 clinical trial evaluating Company’s ...

This development marks a step forward in Vaxart’s efforts to address the significant global health challenge posed by norovirus ... and Drug Administration (FDA). If these stages are achieved ...

Norovirus is a leading cause of acute gastroenteritis worldwide ... followed by an End of Phase 2 meeting with the U.S. Food and Drug Administration (FDA). A Phase 3 trial could then begin as early as ...

Norovirus is a major health concern globally ... Administration’s policies and actions on regulations affecting the FDA and other healthcare agencies and potential staffing issues resulting ...